116 / 119
115
Diretrizes AMB
psoriasis: results from a randomized, double-blind, placebo-controlled
phase 2/3 trial. J Dermatol. 2012 Sep;39(9):761-9. PubMed PMID:
22409383.
36.
Igarashi A, Kato T, Kato M, Song M, Nakagawa H; Japanese
Ustekinumab Study Group. Efficacy and safety of ustekinumab in
Japanese patients with moderate-to-severe plaque-type psoriasis: long-
term results from a phase 2/3 clinical trial. J Dermatol. 2012
Mar;39(3):242-52. PubMed PMID: 21955098.